Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v8-EN
Language French English
Date Updated 2022-01-14 2022-05-09
Drug Identification Number 02501600 02501600
Brand name INQOVI INQOVI
Common or Proper name cedazuridine and decitabine cedazuridine and decitabine
Company Name OTSUKA PHARMACEUTICAL CO LTD OTSUKA PHARMACEUTICAL CO LTD
Ingredients
Strength(s) 100MG 35MG 100MG 35MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size blister blister
ATC code L01BC L01BC
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-03-15 2022-03-15
Actual start date
Estimated end date 2022-05-01 2022-05-20
Actual end date
Shortage status Anticipated shortage Actual shortage
Tier 3 Status No Yes
Company comments Manufacturing delay Manufacturing delay
Health Canada comments